1Guidelines subcommittee 1999 World Health Organization. International Society of Hypertension Guide lines for the management of Hypertension [J]. Hypertension, 1999,17:151-83.
2Taddei S, Virdis A, giadoni L, et al. Effects of Antihypertensive Drugs on Endothelial Dysfunction : Clinical Implications[J]. Drugs, 2002,62(2):265-284.
3Panza JA,Casino PR,Kilcoyne CM,Quyyumi A.Role of endothelium-derived nitric oxide in theabnormal endothelium-dependment vasorelaxation of patients with esssentialhypertension [J]. Circulation, 1993,87:1 468-1 474.
4Grunfied S,Hamiton CA Mesaros S,et al. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats[ J ]. hypertens, 1995,26 ( 6 ) part 1: 854-857.
5Kerr S, Brosnan M J, Melntyre M, et al. superoxide anion production is increasedin a model of genetic hypertension: the role of the endothelium[ J]. hypertens, 1999,33:1 353-1 358.
6Taddei S ,Virdis A, Ghiadoni L, et al. Vitamine C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension [ J]. Circulation, 1998, 97:2 222-2 229.
